Taubman Institute Emerging Scholar hosting AD researcher at Neurology/Neuroscience seminar

Emerging Scholar Sami Barmada, MD, PhD, has invited Dena Dubal, MD, PhD, to speak at Michigan Medicine’s Neurology/Neuroscience seminar Friday, September 25 at Noon-1 pm via Zoom. Dr. Dubal’s presentation is titled, “Mechanisms of Sex Bias in Alzheimer’s Disease: X Marks the Spot.” Whether sex chromosomes contribute to sex difference in Alzheimer’s disease (AD) is…

Taubman Scholar reviews possible blood test to detect Alzheimer’s

Earlier, less intrusive and less costly tests for Alzheimer’s disease would allow doctors to try intervention therapies earlier in the disorder’s development, in hopes of slowing or curbing progression of the disease. Taubman Scholar Henry Paulson, MD, PhD, was interviewed recently about some new blood tests making the news among dementia researchers. Read what he…

Project Review Webinar: Transplantation Immunology

Join Michigan Medicine’s Daniel Goldstein, MD and renowned human transplantation immunology researchers October 12 at 9 am-Noon for an update on their Taubman Institute Innovation Project (TIIP) that aims to refine the use of immune-suppression drugs in solid organ transplant patients. Dr. Goldstein heads a team of three Michigan Medicine primary investigators in this TIIP,…

Precision Medicine for Ocular Diseases

Studying and deciphering vision-related diseases is complicated by the delicate structure of the eye itself. While biopsies and samples from many other bodily systems are relatively easily obtained by physicians, collecting the vitreous fluid from within the eye is a more challenging task and often fails. The lack of a standardized process to collect and…

Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.

Funding from the Taubman Institute has helped a team of researchers develop a new approach to treating aggressive brain tumors. Daniel Wahl, MD, PhD, a radiation oncologist and researcher at Michigan Medicine, says an existing drug used to prevent organ transplant rejection may make radiation therapy more effective for glioblastoma patients by targeting a critical…

Taubman Scholar Named Chair, Dept. of Pediatrics

The Taubman Institute congratulates Donna M. Martin, MD, PhD, who was appointed chair of the Department of Pediatrics. She also became the Ravitz Foundation Endowed Professor of Pediatrics and Communicable Diseases. Dr. Martin is the Donita B. Sullivan, M.D., Research Professor of Pediatrics and Communicable Diseases, and a professor of pediatrics and human genetics in…

Beyond Just Pictures: Multi-scale, Quantitative Imaging

Imaging studies encompass scales of resolution from molecules to patients. Join us Thursday, Aug. 20 at Noon-1 pm via Zoom for this Taubman Technology Talks webinar. Gary Luker, MD, will present several different technologies to meet demands of imaging studies and computational approaches to extract quantitative imaging data from imaging studies. Dr. Luker is a…

Taubman Institute funds early-detection COVID study that uses wearable devices

Early in the wake of the pandemic as new epidemiological data were emerging, a major concern shared by healthcare workers (HCWs) was the potential to transmit virus without any warning signs. A critical unaddressed issue is whether early detection, especially of infection before obvious symptoms, can prevent “pre-symptomatic transmission” and stop further spread.   Sung…

Institute supports first U-M based COVID study

A team of University of Michigan physician-researchers have launched a clinical trial of a drug they believe may address the deadly blood clots that form in some patients with COVID-19. The trial is the first COVID-related investigation to be initiated by Michigan Medicine scientists. The trial is based on the results of a blood inflammation…

TIIP investigator will study immune response in COVID patients

A Michigan Medicine physician-investigator and recipient of a Taubman Institute Innovation Projects (TIIP) grant will use samples from COVID-19 patients to study how the virus affects a patient’s immune profile. Daniel Goldstein, MD,  last year began a TIIP study that will scrutinize the immune system of organ transplant patients in an effort to refine the…